title: Melatonin attenuates renal ischemia-reperfusion injury in nitric oxide synthase inhibited rats.
abstract: Recent studies show that melatonin reduces the blood pressure (BP) and ischemia/reperfusion (I/R)-induced damage. This study was designed to investigate the effects of melatonin on the renal I/R injury in rats given the nitric oxide synthase (NOS) inhibitor, N(omega)-nitro-L-arginine methyl ester (L-NAME). After right nephrectomy, I/R was induced by occlusion of the left renal vessels for 60 min, followed by 24h reperfusion. The administration of melatonin significantly attenuated BP in NOS-inhibited hypertensive rats. Malondialdehyde (MDA) levels, a stable metabolite of the free-radical-mediated lipid peroxidation cascade, were found to be significantly higher in the I/R group (3.48+/-0.2mg/l serum) than in the control group (2.69+/-0.2mg/l serum). L-NAME (40 mgkg(-1) for 15 days)+I/R significantly increased the MDA levels compared to I/R alone. Melatonin administration to L-NAME rats significantly reduced the MDA values resulting from I/R. We also demonstrated that I/R, and especially L-NAME+I/R, lead to structural changes in the kidney and that melatonin attenuates these changes. These results suggest that melatonin reduces BP and I/R injury in NOS inhibited rats by L-NAME.
authors.affiliation: Department of Pharmacology, Faculty of Medicine, Firat University, 23119 Elazig, Turkey.
authors.forename: Esra
authors.initials: E
authors.lastname: Deniz
authors.forename: Neriman
authors.initials: N
authors.lastname: Colakoglu
authors.forename: Aysel
authors.initials: A
authors.lastname: Sari
authors.forename: Mehmet Fatih
authors.initials: MF
authors.lastname: Sonmez
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Tugrul
authors.forename: Suleyman
authors.initials: S
authors.lastname: Oktar
authors.forename: Selcuk
authors.initials: S
authors.lastname: Ilhan
authors.forename: Engin
authors.initials: E
authors.lastname: Sahna
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007668:Kidney / Q000201:enzymology / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D008550:Melatonin / Q000627:therapeutic use*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000188:drug therapy*
chemical_list: D004791:Enzyme Inhibitors; D008315:Malondialdehyde; D019001:Nitric Oxide Synthase; D008550:Melatonin; D019331:NG-Nitroarginine Methyl Ester